Literature DB >> 12402348

Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.

Kwong Wai Choy1, Chi Pui Pang, Christopher B O Yu, Hing Lok Wong, Joan S K Ng, Dorothy S P Fan, Kwok Wai Lo, Joshua T Y Chai, Jianhua Wang, Weiling Fu, Dennis S C Lam.   

Abstract

We investigated sequence alternation, promoter methylation, and loss of heterozygosity (LOH) of the RB1 gene as possible mechanisms of its inactivation in retinoblastoma. In 42 Chinese patients with sporadic retinoblastoma, the promoter and entire coding region of RB1 were examined for sequence changes. Status of methylation of the CpG-rich island at the 5'end was determined by methylation specific PCR assay. We detected 15 RB1 mutations in 38% (16/42) of the retinoblastoma patients, among them 19% (8/42) were germ-line mutations. A total of nine novel mutations were identified: E54X, S114X, I126S, g73779insG, D718N, IVS2+1G>C, IVS14+1G>C, IVS21+1G>C, and a complex alteration g78177G>T/g78176insTT leading to 543X. Most of them are likely to affect the RB1large pocket domain through the production of truncated gene products. None of the DNA samples showed methylation at the RB1promoter. In 15 cases where both normal and cancerous retinoblastoma tissue specimens were available, allelic loss according to microsatellite markers within or distal to the RB1 locus was analyzed and immunohistological staining for RB1 expression performed. Among them, frequency of LOH at 13q14 was found to be high at 60% (9/15) with no segregation with unilateral tumors. All these nine tumors did not express RB1 protein, showing an association of LOH at the RB1 locus with its loss of expression in retinoblastoma. Our results indicate that the RB1 gene in sporadic retinoblastoma is commonly inactivated because of loss-of-function mutations and loss of heterozygosity but not by the epigenetic phenomenon of promoter hypermethylation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402348     DOI: 10.1002/humu.9077

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Genetic screening in Iranian patients with retinoblastoma.

Authors:  K Shahraki; A Ahani; P Sharma; M Faranoush; G Bahoush; I Torktaz; W A Gahl; M Naseripour; B Behnam
Journal:  Eye (Lond)       Date:  2016-12-16       Impact factor: 3.775

2.  Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.

Authors:  Wai Kit Chu; Ka Sin Law; Sun On Chan; Jason Cheuk Sing Yam; Li Jia Chen; Hao Zhang; Herman S Cheung; Norman L Block; Andrew V Schally; Chi Pui Pang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-23       Impact factor: 11.205

3.  Retinoblastoma in India : microsatellite analysis and its application in genetic counseling.

Authors:  Vedam L Ramprasad; Jagadeesan Madhavan; Sakthivel Murugan; Jagadeesh Sujatha; Seshadri Suresh; Tarun Sharma; Govindasamy Kumaramanickavel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals 11 novel mutations.

Authors:  Katia Sampieri; Theodora Hadjistilianou; Francesca Mari; Caterina Speciale; Maria Antonietta Mencarelli; Francesco Cetta; Siranoush Manoukian; Bernard Peissel; Daniela Giachino; Barbara Pasini; Antonio Acquaviva; Aldo Caporossi; Renato Frezzotti; Alessandra Renieri; Mirella Bruttini
Journal:  J Hum Genet       Date:  2006-02-04       Impact factor: 3.172

5.  Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Kashif Ali; Ishrat Mahjabeen; Muhammad Saeed; Mahmood Akhtar Kayani
Journal:  Cell Oncol (Dordr)       Date:  2014-06-03       Impact factor: 6.730

6.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

7.  The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas.

Authors:  Jason I Herschkowitz; Xiaping He; Cheng Fan; Charles M Perou
Journal:  Breast Cancer Res       Date:  2008-09-09       Impact factor: 6.466

8.  Retinoblastoma genetics screening and clinical management.

Authors:  Himika Gupta; Sivasankar Malaichamy; Ashwin Mallipatna; Sakthivel Murugan; Nallathambi Jeyabalan; Vishnu Suresh Babu; Anuprita Ghosh; Arkasubhra Ghosh; Sam Santhosh; Somasekar Seshagiri; Vedam L Ramprasad; Govindasamy Kumaramanickavel
Journal:  BMC Med Genomics       Date:  2021-07-22       Impact factor: 3.063

9.  Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas.

Authors:  Ruojin Ren; Weiwei Liu; Li Huang; David Tai Li Liu; Kwong Wai Choy; Jitong Shi; Junyang Zhao; Bowen Zhao; Ming Guan; Carol L Shields; Chi Pui Pang; Bin Li; Gary Hin Fai Yam
Journal:  Mol Vis       Date:  2013-03-15       Impact factor: 2.367

10.  Genotyping of Polymorphic Microsatellite Markers Linked to RB1 Locus in Iranian Population.

Authors:  Saman Mohamad Zahery; Kioomars Saliminejad; Hamid Reza Khorram Khorshid; Ali Ahani
Journal:  Avicenna J Med Biotechnol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.